Evoke Pharma Participates in Nationwide Gastroenterology Conference
Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on developing treatments for gastrointestinal (GI) diseases, has announced its involvement in the Gastroenterology and Hepatology Advanced Practice Providers Conference. This important event will take place over three days at the Gaylord National Resort in National Harbor.
Matt D’Onofrio, the CEO of Evoke Pharma, shared his enthusiasm about the company's ongoing sponsorship of this crucial conference, which centers on nurse practitioners and physician assistants who play a vital role in managing patients with GI disorders. D’Onofrio remarked, "This event not only allows us to connect with advanced practice providers but also fosters meaningful conversations about GIMOTI and its impact on improving the lives of patients suffering from diabetic gastroparesis. We are excited to engage with this community and share our insights on specialized treatment approaches."
During the conference, Evoke Pharma's management team, along with its commercial representatives, will set up a booth to encourage interactions and discussions with attendees. This hands-on engagement will help healthcare providers learn about the innovative solutions Evoke has to offer.
Understanding Gastroparesis and the Significance of GIMOTI
Demittre Sorenson, a physician assistant at the Center for Advanced GI, highlighted the critical role of GIMOTI in managing gastroparesis. Sorenson stated, "In my extensive experience with GI patients, I often see the challenges faced by those suffering from gastroparesis. GIMOTI's nasal delivery system offers a promising alternative that can lead to better outcomes compared to traditional oral medications. It provides essential relief, particularly when symptoms are severe, since it does not rely on the stomach's ability to process medication effectively."
This insight underscores the potential of GIMOTI to greatly improve the quality of life for patients dealing with this difficult condition, which affects millions around the world.
About the Gastroenterology and Hepatology Advanced Practice Providers
The GHAPP organization is dedicated to enhancing the professional development and education of advanced practice providers focused on managing GI disorders. This annual conference serves as a vital platform for healthcare professionals, addressing the unique needs and challenges they encounter in their practice.
As the only national conference specifically designed for advanced practice providers in gastroenterology, it promotes a deeper understanding of innovative treatments and offers opportunities to exchange best practices among peers.
Innovative Treatments Leading the Way
Evoke Pharma has established itself in the pharmaceutical field by concentrating on the development of specialized medications for GI disorders. One of their primary products is GIMOTI, which is specifically designed to treat diabetic gastroparesis in adults. This condition prevents the stomach from emptying its contents properly, leading to various serious complications.
Prior to GIMOTI's market introduction, metoclopramide was only available in oral or injectable forms, limiting patient options. Now, GIMOTI serves as a crucial alternative, being the only FDA-approved treatment for gastroparesis currently available in the United States.
Discover More About Evoke Pharma
For those interested in learning more about Evoke Pharma's innovative offerings and updates, visiting their official website is recommended. The company's commitment to advancing GI treatment remains a fundamental aspect of their mission as they work to address the growing needs of patients and healthcare providers alike.
Frequently Asked Questions
What is Evoke Pharma focusing on during the GHAPP conference?
Evoke Pharma is focused on engaging healthcare providers and discussing their innovative treatment GIMOTI, particularly its effectiveness for diabetic gastroparesis.
What is GIMOTI?
GIMOTI is a nasal spray formulation of metoclopramide designed to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults.
What is the role of the GHAPP organization?
The GHAPP organization aims to provide education, resources, and professional advancement opportunities for advanced practice providers specializing in gastroenterology.
Why is the GHAPP conference important for advanced practice providers?
The conference is specifically designed to address the educational needs of providers who deal with GI disorders, offering them insights and peer discussions on best practices.
How can patients benefit from GIMOTI?
Patients benefit from GIMOTI as it offers an effective treatment option that does not rely on the stomach's ability to absorb medications, significantly improving their treatment experience.
